0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-Peptic Ulcer Drugs Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-3301
Home | Market Reports
China Anti Peptic Ulcer Drugs Market Report Forecast 2021 2027
BUY CHAPTERS

Global Anti-Peptic Ulcer Drugs Market Research Report 2026

Code: QYRE-Auto-3301
Report
2026-02-03
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-Peptic Ulcer Drugs Market Size

The global Anti-Peptic Ulcer Drugs market was valued at US$ 12530 million in 2025 and is anticipated to reach US$ 29860 million by 2032, at a CAGR of 13.4% from 2026 to 2032.

Anti-Peptic Ulcer Drugs Market

Anti-Peptic Ulcer Drugs Market

Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
Global Anti-Peptic Ulcer Drugs key players include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, etc. Global top five players hold a share about 50%.
In terms of product, the segment includes Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs. And in terms of application, the application includes Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD).
This report delivers a comprehensive overview of the global Anti-Peptic Ulcer Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anti-Peptic Ulcer Drugs. The Anti-Peptic Ulcer Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Anti-Peptic Ulcer Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-Peptic Ulcer Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Anti-Peptic Ulcer Drugs Market Report

Report Metric Details
Report Name Anti-Peptic Ulcer Drugs Market
Accounted market size in 2025 US$ 12530 million
Forecasted market size in 2032 US$ 29860 million
CAGR 13.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Proton Pump Inhibitors (PPIs)
  • Potassium-Competitive Acid Blockers (P-CAB)
  • Antacids
  • H2 Antagonists
  • Ulcer Protective Drugs
Segment by Application
  • Gastritis
  • Gastric Ulcers
  • Duodenal Ulcers
  • Gastroesophageal Reflux Disease (GERD)
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, Huadong Medicine, Changzhou Siyao, Beijing Yuekang, Guangdong Dahua, Xian Janssen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Anti-Peptic Ulcer Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Anti-Peptic Ulcer Drugs Market growing?

Ans: The Anti-Peptic Ulcer Drugs Market witnessing a CAGR of 13.4% during the forecast period 2026-2032.

What is the Anti-Peptic Ulcer Drugs Market size in 2032?

Ans: The Anti-Peptic Ulcer Drugs Market size in 2032 will be US$ 29860 million.

What is the market share of major companies in Anti-Peptic Ulcer Drugs Market?

Ans: Global top five players hold a share about 50%.

Who are the main players in the Anti-Peptic Ulcer Drugs Market report?

Ans: The main players in the Anti-Peptic Ulcer Drugs Market are AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, Huadong Medicine, Changzhou Siyao, Beijing Yuekang, Guangdong Dahua, Xian Janssen

What are the Application segmentation covered in the Anti-Peptic Ulcer Drugs Market report?

Ans: The Applications covered in the Anti-Peptic Ulcer Drugs Market report are Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD)

What are the Type segmentation covered in the Anti-Peptic Ulcer Drugs Market report?

Ans: The Types covered in the Anti-Peptic Ulcer Drugs Market report are Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Proton Pump Inhibitors (PPIs)
1.2.3 Potassium-Competitive Acid Blockers (P-CAB)
1.2.4 Antacids
1.2.5 H2 Antagonists
1.2.6 Ulcer Protective Drugs
1.3 Market by Application
1.3.1 Global Anti-Peptic Ulcer Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Gastritis
1.3.3 Gastric Ulcers
1.3.4 Duodenal Ulcers
1.3.5 Gastroesophageal Reflux Disease (GERD)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Peptic Ulcer Drugs Market Perspective (2021–2032)
2.2 Global Anti-Peptic Ulcer Drugs Growth Trends by Region
2.2.1 Global Anti-Peptic Ulcer Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Anti-Peptic Ulcer Drugs Historic Market Size by Region (2021–2026)
2.2.3 Anti-Peptic Ulcer Drugs Forecasted Market Size by Region (2027–2032)
2.3 Anti-Peptic Ulcer Drugs Market Dynamics
2.3.1 Anti-Peptic Ulcer Drugs Industry Trends
2.3.2 Anti-Peptic Ulcer Drugs Market Drivers
2.3.3 Anti-Peptic Ulcer Drugs Market Challenges
2.3.4 Anti-Peptic Ulcer Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Peptic Ulcer Drugs Players by Revenue
3.1.1 Global Top Anti-Peptic Ulcer Drugs Players by Revenue (2021–2026)
3.1.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Anti-Peptic Ulcer Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Anti-Peptic Ulcer Drugs Revenue
3.4 Global Anti-Peptic Ulcer Drugs Market Concentration Ratio
3.4.1 Global Anti-Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Peptic Ulcer Drugs Revenue in 2025
3.5 Global Key Players of Anti-Peptic Ulcer Drugs Head Offices and Areas Served
3.6 Global Key Players of Anti-Peptic Ulcer Drugs, Products and Applications
3.7 Global Key Players of Anti-Peptic Ulcer Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Anti-Peptic Ulcer Drugs Breakdown Data by Type
4.1 Global Anti-Peptic Ulcer Drugs Historic Market Size by Type (2021–2026)
4.2 Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Type (2027–2032)
5 Anti-Peptic Ulcer Drugs Breakdown Data by Application
5.1 Global Anti-Peptic Ulcer Drugs Historic Market Size by Application (2021–2026)
5.2 Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Anti-Peptic Ulcer Drugs Market Size (2021–2032)
6.2 North America Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Anti-Peptic Ulcer Drugs Market Size by Country (2021–2026)
6.4 North America Anti-Peptic Ulcer Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-Peptic Ulcer Drugs Market Size (2021–2032)
7.2 Europe Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Anti-Peptic Ulcer Drugs Market Size by Country (2021–2026)
7.4 Europe Anti-Peptic Ulcer Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size (2021–2032)
8.2 Asia-Pacific Anti-Peptic Ulcer Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Anti-Peptic Ulcer Drugs Market Size (2021–2032)
9.2 Latin America Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Anti-Peptic Ulcer Drugs Market Size by Country (2021–2026)
9.4 Latin America Anti-Peptic Ulcer Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size (2021–2032)
10.2 Middle East & Africa Anti-Peptic Ulcer Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Introduction
11.1.4 AstraZeneca Revenue in Anti-Peptic Ulcer Drugs Business (2021–2026)
11.1.5 AstraZeneca Recent Development
11.2 Ask-pharm
11.2.1 Ask-pharm Company Details
11.2.2 Ask-pharm Business Overview
11.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Introduction
11.2.4 Ask-pharm Revenue in Anti-Peptic Ulcer Drugs Business (2021–2026)
11.2.5 Ask-pharm Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Anti-Peptic Ulcer Drugs Introduction
11.3.4 Takeda Revenue in Anti-Peptic Ulcer Drugs Business (2021–2026)
11.3.5 Takeda Recent Development
11.4 Yangtze River Pharm
11.4.1 Yangtze River Pharm Company Details
11.4.2 Yangtze River Pharm Business Overview
11.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Introduction
11.4.4 Yangtze River Pharm Revenue in Anti-Peptic Ulcer Drugs Business (2021–2026)
11.4.5 Yangtze River Pharm Recent Development
11.5 Shandong Luoxin
11.5.1 Shandong Luoxin Company Details
11.5.2 Shandong Luoxin Business Overview
11.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Introduction
11.5.4 Shandong Luoxin Revenue in Anti-Peptic Ulcer Drugs Business (2021–2026)
11.5.5 Shandong Luoxin Recent Development
11.6 Huadong Medicine
11.6.1 Huadong Medicine Company Details
11.6.2 Huadong Medicine Business Overview
11.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Introduction
11.6.4 Huadong Medicine Revenue in Anti-Peptic Ulcer Drugs Business (2021–2026)
11.6.5 Huadong Medicine Recent Development
11.7 Changzhou Siyao
11.7.1 Changzhou Siyao Company Details
11.7.2 Changzhou Siyao Business Overview
11.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Introduction
11.7.4 Changzhou Siyao Revenue in Anti-Peptic Ulcer Drugs Business (2021–2026)
11.7.5 Changzhou Siyao Recent Development
11.8 Beijing Yuekang
11.8.1 Beijing Yuekang Company Details
11.8.2 Beijing Yuekang Business Overview
11.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Introduction
11.8.4 Beijing Yuekang Revenue in Anti-Peptic Ulcer Drugs Business (2021–2026)
11.8.5 Beijing Yuekang Recent Development
11.9 Guangdong Dahua
11.9.1 Guangdong Dahua Company Details
11.9.2 Guangdong Dahua Business Overview
11.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Introduction
11.9.4 Guangdong Dahua Revenue in Anti-Peptic Ulcer Drugs Business (2021–2026)
11.9.5 Guangdong Dahua Recent Development
11.10 Xian Janssen
11.10.1 Xian Janssen Company Details
11.10.2 Xian Janssen Business Overview
11.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Introduction
11.10.4 Xian Janssen Revenue in Anti-Peptic Ulcer Drugs Business (2021–2026)
11.10.5 Xian Janssen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Proton Pump Inhibitors (PPIs)
 Table 3. Key Players of Potassium-Competitive Acid Blockers (P-CAB)
 Table 4. Key Players of Antacids
 Table 5. Key Players of H2 Antagonists
 Table 6. Key Players of Ulcer Protective Drugs
 Table 7. Global Anti-Peptic Ulcer Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Anti-Peptic Ulcer Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 9. Global Anti-Peptic Ulcer Drugs Market Size by Region (US$ Million), 2021–2026
 Table 10. Global Anti-Peptic Ulcer Drugs Market Share by Region (2021–2026)
 Table 11. Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 12. Global Anti-Peptic Ulcer Drugs Market Share by Region (2027–2032)
 Table 13. Anti-Peptic Ulcer Drugs Market Trends
 Table 14. Anti-Peptic Ulcer Drugs Market Drivers
 Table 15. Anti-Peptic Ulcer Drugs Market Challenges
 Table 16. Anti-Peptic Ulcer Drugs Market Restraints
 Table 17. Global Anti-Peptic Ulcer Drugs Revenue by Players (US$ Million), 2021–2026
 Table 18. Global Anti-Peptic Ulcer Drugs Market Share by Players (2021–2026)
 Table 19. Global Top Anti-Peptic Ulcer Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Anti-Peptic Ulcer Drugs Revenue, 2025
 Table 20. Ranking of Global Top Anti-Peptic Ulcer Drugs Companies by Revenue (US$ Million) in 2025
 Table 21. Global 5 Largest Players Market Share by Anti-Peptic Ulcer Drugs Revenue (CR5 and HHI), 2021–2026
 Table 22. Global Key Players of Anti-Peptic Ulcer Drugs, Headquarters and Area Served
 Table 23. Global Key Players of Anti-Peptic Ulcer Drugs, Products and Applications
 Table 24. Global Key Players of Anti-Peptic Ulcer Drugs, Date of General Availability (GA)
 Table 25. Mergers and Acquisitions, Expansion Plans
 Table 26. Global Anti-Peptic Ulcer Drugs Market Size by Type (US$ Million), 2021–2026
 Table 27. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2021–2026)
 Table 28. Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 29. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2027–2032)
 Table 30. Global Anti-Peptic Ulcer Drugs Market Size by Application (US$ Million), 2021–2026
 Table 31. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2021–2026)
 Table 32. Global Anti-Peptic Ulcer Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 33. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2027–2032)
 Table 34. North America Anti-Peptic Ulcer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. North America Anti-Peptic Ulcer Drugs Market Size by Country (US$ Million), 2021–2026
 Table 36. North America Anti-Peptic Ulcer Drugs Market Size by Country (US$ Million), 2027–2032
 Table 37. Europe Anti-Peptic Ulcer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Europe Anti-Peptic Ulcer Drugs Market Size by Country (US$ Million), 2021–2026
 Table 39. Europe Anti-Peptic Ulcer Drugs Market Size by Country (US$ Million), 2027–2032
 Table 40. Asia-Pacific Anti-Peptic Ulcer Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Region (US$ Million), 2021–2026
 Table 42. Asia-Pacific Anti-Peptic Ulcer Drugs Market Size by Region (US$ Million), 2027–2032
 Table 43. Latin America Anti-Peptic Ulcer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Latin America Anti-Peptic Ulcer Drugs Market Size by Country (US$ Million), 2021–2026
 Table 45. Latin America Anti-Peptic Ulcer Drugs Market Size by Country (US$ Million), 2027–2032
 Table 46. Middle East & Africa Anti-Peptic Ulcer Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 47. Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (US$ Million), 2021–2026
 Table 48. Middle East & Africa Anti-Peptic Ulcer Drugs Market Size by Country (US$ Million), 2027–2032
 Table 49. AstraZeneca Company Details
 Table 50. AstraZeneca Business Overview
 Table 51. AstraZeneca Anti-Peptic Ulcer Drugs Product
 Table 52. AstraZeneca Revenue in Anti-Peptic Ulcer Drugs Business (US$ Million), 2021–2026
 Table 53. AstraZeneca Recent Development
 Table 54. Ask-pharm Company Details
 Table 55. Ask-pharm Business Overview
 Table 56. Ask-pharm Anti-Peptic Ulcer Drugs Product
 Table 57. Ask-pharm Revenue in Anti-Peptic Ulcer Drugs Business (US$ Million), 2021–2026
 Table 58. Ask-pharm Recent Development
 Table 59. Takeda Company Details
 Table 60. Takeda Business Overview
 Table 61. Takeda Anti-Peptic Ulcer Drugs Product
 Table 62. Takeda Revenue in Anti-Peptic Ulcer Drugs Business (US$ Million), 2021–2026
 Table 63. Takeda Recent Development
 Table 64. Yangtze River Pharm Company Details
 Table 65. Yangtze River Pharm Business Overview
 Table 66. Yangtze River Pharm Anti-Peptic Ulcer Drugs Product
 Table 67. Yangtze River Pharm Revenue in Anti-Peptic Ulcer Drugs Business (US$ Million), 2021–2026
 Table 68. Yangtze River Pharm Recent Development
 Table 69. Shandong Luoxin Company Details
 Table 70. Shandong Luoxin Business Overview
 Table 71. Shandong Luoxin Anti-Peptic Ulcer Drugs Product
 Table 72. Shandong Luoxin Revenue in Anti-Peptic Ulcer Drugs Business (US$ Million), 2021–2026
 Table 73. Shandong Luoxin Recent Development
 Table 74. Huadong Medicine Company Details
 Table 75. Huadong Medicine Business Overview
 Table 76. Huadong Medicine Anti-Peptic Ulcer Drugs Product
 Table 77. Huadong Medicine Revenue in Anti-Peptic Ulcer Drugs Business (US$ Million), 2021–2026
 Table 78. Huadong Medicine Recent Development
 Table 79. Changzhou Siyao Company Details
 Table 80. Changzhou Siyao Business Overview
 Table 81. Changzhou Siyao Anti-Peptic Ulcer Drugs Product
 Table 82. Changzhou Siyao Revenue in Anti-Peptic Ulcer Drugs Business (US$ Million), 2021–2026
 Table 83. Changzhou Siyao Recent Development
 Table 84. Beijing Yuekang Company Details
 Table 85. Beijing Yuekang Business Overview
 Table 86. Beijing Yuekang Anti-Peptic Ulcer Drugs Product
 Table 87. Beijing Yuekang Revenue in Anti-Peptic Ulcer Drugs Business (US$ Million), 2021–2026
 Table 88. Beijing Yuekang Recent Development
 Table 89. Guangdong Dahua Company Details
 Table 90. Guangdong Dahua Business Overview
 Table 91. Guangdong Dahua Anti-Peptic Ulcer Drugs Product
 Table 92. Guangdong Dahua Revenue in Anti-Peptic Ulcer Drugs Business (US$ Million), 2021–2026
 Table 93. Guangdong Dahua Recent Development
 Table 94. Xian Janssen Company Details
 Table 95. Xian Janssen Business Overview
 Table 96. Xian Janssen Anti-Peptic Ulcer Drugs Product
 Table 97. Xian Janssen Revenue in Anti-Peptic Ulcer Drugs Business (US$ Million), 2021–2026
 Table 98. Xian Janssen Recent Development
 Table 99. Research Programs/Design for This Report
 Table 100. Key Data Information from Secondary Sources
 Table 101. Key Data Information from Primary Sources
 Table 102. Authors List of This Report


List of Figures
 Figure 1. Anti-Peptic Ulcer Drugs Picture
 Figure 2. Global Anti-Peptic Ulcer Drugs Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Anti-Peptic Ulcer Drugs Market Share by Type: 2025 vs 2032
 Figure 4. Proton Pump Inhibitors (PPIs) Features
 Figure 5. Potassium-Competitive Acid Blockers (P-CAB) Features
 Figure 6. Antacids Features
 Figure 7. H2 Antagonists Features
 Figure 8. Ulcer Protective Drugs Features
 Figure 9. Global Anti-Peptic Ulcer Drugs Market Size by Application (US$ Million), 2021–2032
 Figure 10. Global Anti-Peptic Ulcer Drugs Market Share by Application: 2025 vs 2032
 Figure 11. Gastritis Case Studies
 Figure 12. Gastric Ulcers Case Studies
 Figure 13. Duodenal Ulcers Case Studies
 Figure 14. Gastroesophageal Reflux Disease (GERD) Case Studies
 Figure 15. Anti-Peptic Ulcer Drugs Report Years Considered
 Figure 16. Global Anti-Peptic Ulcer Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 17. Global Anti-Peptic Ulcer Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Anti-Peptic Ulcer Drugs Market Share by Region: 2025 vs 2032
 Figure 19. Global Anti-Peptic Ulcer Drugs Market Share by Players in 2025
 Figure 20. Global Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 21. The Top 10 and 5 Players Market Share by Anti-Peptic Ulcer Drugs Revenue in 2025
 Figure 22. North America Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. North America Anti-Peptic Ulcer Drugs Market Share by Country (2021–2032)
 Figure 24. United States Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Canada Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Europe Anti-Peptic Ulcer Drugs Market Share by Country (2021–2032)
 Figure 28. Germany Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. France Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. U.K. Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Italy Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Russia Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Ireland Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Asia-Pacific Anti-Peptic Ulcer Drugs Market Share by Region (2021–2032)
 Figure 36. China Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Japan Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. South Korea Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Southeast Asia Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. India Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Australia & New Zealand Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Latin America Anti-Peptic Ulcer Drugs Market Share by Country (2021–2032)
 Figure 44. Mexico Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Brazil Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Middle East & Africa Anti-Peptic Ulcer Drugs Market Share by Country (2021–2032)
 Figure 48. Israel Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. UAE Anti-Peptic Ulcer Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. AstraZeneca Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2021–2026)
 Figure 52. Ask-pharm Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2021–2026)
 Figure 53. Takeda Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2021–2026)
 Figure 54. Yangtze River Pharm Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2021–2026)
 Figure 55. Shandong Luoxin Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2021–2026)
 Figure 56. Huadong Medicine Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2021–2026)
 Figure 57. Changzhou Siyao Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2021–2026)
 Figure 58. Beijing Yuekang Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2021–2026)
 Figure 59. Guangdong Dahua Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2021–2026)
 Figure 60. Xian Janssen Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2021–2026)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India